Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Methoprene-tolerant protein (Met) is the primary receptor for juvenile hormone (JH), a critical sesquiterpenoid that orchestrates insect metamorphosis, molting, and reproduction (Jindra et al., 2013, Annual Review of Entomology). As a member of the basic helix-loop-helix-Per-Arnt-Sim (bHLH-PAS) family of transcription factors, Met binds JH with high affinity and subsequently forms a heterodimer with the co-activator protein Taiman (Tai) (Charles et al., 2011, PNAS). This transcriptional complex binds to JH-response elements in the promoter regions of target genes, most notably Krüppel-homolog 1 (Kr-h1), which acts to repress the genes required for metamorphosis (Miyakawa et al., 2013, Vitam Horm). By maintaining the insect in a juvenile state, Met signaling prevents premature transition to the pupal or adult stages. Because JH signaling is unique to arthropods and absent in vertebrates, Met is a premier target for biorational insecticides known as juvenile hormone analogs (JHAs) (Bitra and Palli, 2009, Journal of Biological Chemistry). These compounds, such as methoprene and pyriproxyfen, act as potent agonists that disrupt the endocrine balance of pests, leading to developmental failure, sterility, or death, making them essential for controlling agricultural pests and disease vectors like mosquitoes.
Agonism of the juvenile hormone receptor to mimic natural hormone signaling, thereby disrupting metamorphosis and reproductive cycles in insects.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methoprene-tolerant protein (Met) (Met).